1. Home
  2. TLN vs JAZZ Comparison

TLN vs JAZZ Comparison

Compare TLN & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TLN

Talen Energy Corporation

HOLD

Current Price

$356.92

Market Cap

15.7B

Sector

Utilities

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$248.36

Market Cap

16.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLN
JAZZ
Founded
2015
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7B
16.1B
IPO Year
2014
2007

Fundamental Metrics

Financial Performance
Metric
TLN
JAZZ
Price
$356.92
$248.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
14
Target Price
$432.08
$217.57
AVG Volume (30 Days)
732.1K
744.2K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
7.17
Revenue
$2,581,000,000.00
$1,618,693,000.00
Revenue This Year
$59.63
$6.22
Revenue Next Year
$16.08
$7.68
P/E Ratio
N/A
$34.16
Revenue Growth
22.03
N/A
52 Week Low
$301.45
$117.70
52 Week High
$451.28
$265.05

Technical Indicators

Market Signals
Indicator
TLN
JAZZ
Relative Strength Index (RSI) 50.16 46.81
Support Level $355.60 $222.49
Resistance Level $405.34 $250.49
Average True Range (ATR) 15.61 7.25
MACD 3.62 -2.03
Stochastic Oscillator 72.87 24.96

Price Performance

Historical Comparison
TLN
JAZZ

About TLN Talen Energy Corporation

Talen Energy Corp is an independent power producer and energy infrastructure company based in the United States. It owns and operates several gigawatts of power infrastructure in the United States, including 2.2GW of nuclear power and a dispatchable fossil fleet. The company produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, with its generation fleet principally located in the Mid-Atlantic, Ohio, and Montana. Talen's operating segments are: PJM and Others. The PJM segment, which generates maximum revenue, is engaged in electricity generation, marketing activities, and commodity risk and fuel management within the PJM market and is comprised of Susquehanna and Talen's natural gas and coal generation facilities in PJM.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: